Exposure to cerebrospinal fluid of sporadic Amyotrophic Lateral Sclerosis patients alters Nav1.6 and Kv1.6 channel expression in rat spinal motor neurons

Brain Research

Volumn 1255, Issue , 2009, Pages 170-179

  Gunasekaran, R ^a   Narayani, R Sankara ^a   Vijayalakshmi, K ^a   Alladi, Phalguni Anand ^a   Shobha, K ^a   Nalini, A ^a   Sathyaprabha, T N ^a   Raju, T R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

ALS CSF; BDNF; CNTF; Immunocytochemistry; Nav1.6 sodium and Kv1.6 potassium channel; Spinal motor neuron

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; POTASSIUM CHANNEL KV1.6; SODIUM CHANNEL; SODIUM CHANNEL NAV1.6; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ARTICLE; CEREBROSPINAL FLUID; EMBRYO; HUMAN; IMMUNOHISTOCHEMISTRY; MOTONEURON; NERVE CELL DEGENERATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD; SPINAL CORD NERVE CELL; TISSUE CULTURE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANIMALS, NEWBORN; BIOLOGICAL FACTORS; CELLS, CULTURED; CEREBROSPINAL FLUID; GENE EXPRESSION REGULATION; HUMANS; INJECTIONS, SPINAL; KV1.6 POTASSIUM CHANNEL; MICROINJECTIONS; MOTOR NEURONS; RATS; RATS, WISTAR; SODIUM CHANNELS; SPINAL CORD;

RATTUS;

EID: 59249109196     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.11.099     Document Type: Article

References (56)

1. Anand P., Parrett A., Martin J., Zeman S., Foley P., Swash M., Leigh P.N., Cedarbaum J.M., Lindsay R.M., and Williams-Chestnut R.E. Regional changes of ciliary neurotrophic factor and nerve growth factor levels in post mortem spinal cord and cerebral cortex from patients with motor disease. Nat. Med. 1 (1995) 168-172
2. Arakawa Y., Sendtner M., and Thoenen H. Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motoneurons in culture: comparison with other neurotrophic factors and cytokines. J. Neurosci. 10 (1990) 3507-3515
3. Boillee S., Vande V.C., and Cleveland D.W. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52 (2006) 39-59
4. Bostock H., Sharief M.K., Reid G., and Murray N.M. Axonal ion channel dysfunction in amyotrophic lateral sclerosis. Brain 118 Pt 1 (1995) 217-225
5. Brooks B.R. Clinical epidemiology of amyotrophic lateral sclerosis. Neurol. Clin. 14 (1996) 399-420
6. Brooks B.R. Versailles minimal dataset for diagnosis of ALS: a distillate of the 2nd Consensus Conference on accelerating the diagnosis of ALS. Versailles 2nd Consensus Conference participants. Amyotroph. Lateral. Scler. Other Mot. Neuron Disord. 1 Suppl. 1 (2000) S79-S81
7. Catterall W.A., Goldin A.L., and Waxman S.G. International Union of Pharmacology. XXXIX. Compendium of voltage-gated ion channels: sodium channels. Pharmacol. Rev. 55 (2003) 575-578
8. Clare J.J., Tate S.N., Nobbs M., and Romanos M.A. Voltage-gated sodium channels as therapeutic targets. Drug Discov. Today 5 (2000) 506-520
9. Cohan C.S., and Kater S.B. Suppression of neurite elongation and growth cone motility by electrical activity. Science 232 (1986) 1638-1640
10. Couratier P., Hugon J., Sindou P., Vallat J.M., and Dumas M. Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA/kainate receptors. Lancet 341 (1993) 265-268
11. Duberley R.M., Johnson I.P., Anand P., Swash M., Martin J., Leigh P.N., and Zeman S. Ciliary neurotrophic factor receptor expression in spinal cord and motor cortex in amyotrophic lateral sclerosis. J. Neurol. Sci. 129 (1995) 109-113 Suppl
12. Gao B.X., and Ziskind-Conhaim L. Development of ionic currents underlying changes in action potential waveforms in rat spinal motoneurons. J. Neurophysiol. 80 (1998) 3047-3061
13. Giess R., Holtmann B., Braga M., Grimm T., Muller-Myhsok B., Toyka K.V., and Sendtner M. Early onset of severe familial amyotrophic lateral sclerosis with a SOD-1 mutation: potential impact of CNTF as a candidate modifier gene. Am. J. Hum. Genet. 70 (2002) 1277-1286
14. Goldin A.L. Resurgence of sodium channel research. Annu. Rev. Physiol. 63 (2001) 871-894
15. Goldin A.L., Barchi R.L., Caldwell J.H., Hofmann F., Howe J.R., Hunter J.C., Kallen R.G., Mandel G., Meisler M.H., Netter Y.B., Noda M., Tamkun M.M., Waxman S.G., Wood J.N., and Catterall W.A. Nomenclature of voltage-gated sodium channels. Neuron 28 (2000) 365-368
16. Grabert J., and Wahle P. Neuronal activity and TrkB ligands influence Kv3.1b and Kv3.2 expression in developing cortical interneurons. Neuroscience 156 (2008) 618-629
17. Gutman G.A., Chandy K.G., Grissmer S., Lazdunski M., McKinnon D., Pardo L.A., Robertson G.A., Rudy B., Sanguinetti M.C., Stuhmer W., and Wang X. International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol. Rev. 57 (2005) 473-508
18. Hanson M.G., and Landmesser L.T. Normal patterns of spontaneous activity are required for correct motor axon guidance and the expression of specific guidance molecules. Neuron 43 (2004) 687-701
19. Henderson C.E., Camu W., Mettling C., Gouin A., Poulsen K., Karihaloo M., Rullamas J., Evans T., McMahon S.B., and Armanini M.P. Neurotrophins promote motor neuron survival and are present in embryonic limb bud. Nature 363 (1993) 266-270
20. Hodgkin A.L., and Huxley A.F. Propagation of electrical signals along giant nerve fibers. Proc. R Soc. Lond. B Biol. Sci. 140 (1952) 177-183
21. Ip N.Y., and Zigmond R.E. Pattern of presynaptic nerve activity can determine the type of neurotransmitter regulating a postsynaptic event. Nature 311 (1984) 472-474
22. Kanai K., Kuwabara S., Misawa S., Tamura N., Ogawara K., Nakata M., Sawai S., Hattori T., and Bostock H. Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage. Brain 129 (2006) 953-962
23. Kaplan M.R., Cho M.H., Ullian E.M., Isom L.L., Levinson S.R., and Barres B.A. Differential control of clustering of the sodium channels Na(v)1.2 and Na(v)1.6 at developing CNS nodes of Ranvier. Neuron 30 (2001) 105-119
24. Kuo J.J., Schonewille M., Siddique T., Schults A.N., Fu R., Bar P.R., Anelli R., Heckman C.J., and Kroese A.B. Hyperexcitability of cultured spinal motoneurons from presymptomatic ALS mice. J. Neurophysiol. 91 (2004) 571-575
25. Kuo J.J., Siddique T., Fu R., and Heckman C.J. Increased persistent Na(+) current and its effect on excitability in motoneurones cultured from mutant SOD1 mice. J. Physiol. 563 (2005) 843-854
26. Manabe, Y. and Abe, K., 1999. [Sporadic ALS], Ryoikibetsu. Shokogun. Shirizu. 316-319.
27. Meldrum B.S., and Rogawski M.A. Molecular targets for antiepileptic drug development. Neurotherapeutics 4 (2007) 18-61
28. Mitsumoto H., Ikeda K., Klinkosz B., Cedarbaum J.M., Wong V., and Lindsay R.M. Arrest of motor neuron disease in Wobbler mice cotreated with CNTF and BDNF. Science 265 (1994) 1107-1110
29. Nagaraja T.N., Gourie-Devi M., Nalini A., and Raju T.R. Neurofilament phosphorylation is enhanced in cultured chick spinal cord neurons exposed to cerebrospinal fluid from amyotrophic lateral sclerosis patients. Acta. Neuropathol. 88 (1994) 349-352
30. Nayak M.S., Kim Y.S., Goldman M., Keirstead H.S., and Kerr D.A. Cellular therapies in motor neuron diseases. Biochim. Biophys. Acta 1762 (2006) 1128-1138
31. Park S.Y., Choi J.Y., Kim R.U., Lee Y.S., Cho H.J., and Kim D.S. Downregulation of voltage-gated potassium channel alpha gene expression by axotomy and neurotrophins in rat dorsal root ganglia. Mol. Cells 16 (2003) 256-259
32. Pieri M., Albo F., Gaetti C., Spalloni A., Bengtson C.P., Longone P., Cavalcanti S., and Zona C. Altered excitability of motor neurons in a transgenic mouse model of familial amyotrophic lateral sclerosis. Neurosci. Lett. 351 (2003) 153-156
33. + channels affects zebrafish motoneuron development. Development 133 (2006) 3827-3836
34. Ramamohan P.Y., Gourie-Devi M., Nalini A., Shobha K., Ramamohan Y., Joshi P., and Raju T.R. Cerebrospinal fluid from amyotrophic lateral sclerosis patients causes fragmentation of the Golgi apparatus in the neonatal rat spinal cord. Amyotroph. Lateral. Scler. 8 (2007) 79-82
35. Rao M.S., Devi M.G., Nalini A., Shahani N., and Raju T.R. Neurofilament phosphorylation is increased in ventral horn neurons of neonatal rat spinal cord exposed to cerebrospinal fluid from patients with amyotrophic lateral sclerosis. Neurodegeneration 4 (1995) 397-401
36. Rose C.R., Blum R., Kafitz K.W., Kovalchuk Y., and Konnerth A. From modulator to mediator: rapid effects of BDNF on ion channels. Bioessays 26 (2004) 1185-1194
37. Safronov B.V. Spatial distribution of NA+ and K+ channels in spinal dorsal horn neurones: role of the soma, axon and dendrites in spike generation. Prog. Neurobiol. 59 (1999) 217-241
38. Sendtner M., Kreutzberg G.W., and Thoenen H. Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature 345 (1990) 440-441
39. Shahani N., Nalini A., Gourie-Devi M., and Raju T.R. Reactive astrogliosis in neonatal rat spinal cord after exposure to cerebrospinal fluid from patients with amyotrophic lateral sclerosis. Exp. Neurol. 149 (1998) 295-298
40. Shahani N., Gourie-Devi M., Nalini A., and Raju T.R. Cyclophosphamide attenuates the degenerative changes induced by CSF from patients with amyotrophic lateral sclerosis in the neonatal rat spinal cord. J. Neurol. Sci. 185 (2001) 109-118
41. Shahani N., Gourie-Devi M., Nalini A., Rammohan P., Shobha K., Harsha H.N., and Raju T.R. (-)-Deprenyl alleviates the degenerative changes induced in the neonatal rat spinal cord by CSF from amyotrophic lateral sclerosis patients. Amyotroph. Lateral. Scler. Other Mot. Neuron Disord. 5 (2004) 172-179
42. Shaw P.J. Toxicity of CSF in motor neurone disease: a potential route to neuroprotection. Brain 125 (2002) 693-694
43. Shirahata E., Iwasaki H., Takagi M., Lin C., Bennett V., Okamura Y., and Hayasaka K. Ankyrin-G regulates inactivation gating of the neuronal sodium channel, Nav1.6. J. Neurophysiol. 96 (2006) 1347-1357
44. Shobha K., Vijayalakshmi K., Alladi P.A., Nalini A., Sathyaprabha T.N., and Raju T.R. Altered in-vitro and in-vivo expression of glial glutamate transporter-1 following exposure to cerebrospinal fluid of amyotrophic lateral sclerosis patients. J. Neurol. Sci. 254 (2007) 9-16
45. Soliven B., Ma L., Bae H., Attali B., Sobko A., and Iwase T. PDGF upregulates delayed rectifier via Src family kinases and sphingosine kinase in oligodendroglial progenitors. Am. J. Physiol., Cell Physiol. 284 (2003) C85-C93
46. Takahashi T. Membrane currents in visually identified motoneurones of neonatal rat spinal cord. J. Physiol. 423 (1990) 27-46
47. Terro F., Lesort M., Viader F., Ludolph A., and Hugon J. Antioxidant drugs block in vitro the neurotoxicity of CSF from patients with amyotrophic lateral sclerosis. Neuroreport 7 (1996) 1970-1972
48. Tikka T.M., Vartiainen N.E., Goldsteins G., Oja S.S., Andersen P.M., Marklund S.L., and Koistinaho J. Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neurone disease. Brain 125 (2002) 722-731
49. Utsunomiya I., Yoshihashi E., Tanabe S., Nakatani Y., Ikejima H., Miyatake T., Hoshi K., and Taguchi K. Expression and localization of Kv1 potassium channels in rat dorsal and ventral spinal roots. Exp. Neurol. 210 (2008) 51-58
50. van Es M.A., van Vught P.W., Blauw H.M., Franke L., Saris C.G., Van den B.L., de Jong S.W., de V J., Baas F., van't Slot R., Lemmens R., Schelhaas H.J., Birve A., Sleegers K., Van Broeckhoven C., Schymick J.C., Traynor B.J., Wokke J.H., Wijmenga C., Robberecht W., Andersen P.M., Veldink J.H., Ophoff R.A., and van den Berg L.H. Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis. Nat. Genet 40 (2008) 29-31
51. Wickenden A.D. Potassium channels as anti-epileptic drug targets. Neuropharmacology 43 (2002) 1055-1060
52. Wong V., Arriaga R., Ip N.Y., and Lindsay R.M. The neurotrophins BDNF, NT-3 and NT-4/5, but not NGF, up-regulate the cholinergic phenotype of developing motor neurons. Eur. J. Neurosci. 5 (1993) 466-474
53. Yu F.H., and Catterall W.A. Overview of the voltage-gated sodium channel family. Genome. Biol. 4 (2003) 207
54. Zigmond R.E., and Bowers C.W. Influence of nerve activity of the macromolecular content of neurons and their effector organs. Annu. Rev. Physiol. 43 (1981) 673-687
55. Zona C., Ferri A., Gabbianelli R., Mercuri N.B., Bernardi G., Rotilio G., and Carri M.T. Voltage-activated sodium currents in a cell line expressing a Cu,Zn superoxide dismutase typical of familial ALS. Neuroreport 9 (1998) 3515-3518
56. Zona C., Pieri M., and Carunchio I. Voltage-dependent sodium channels in spinal cord motor neurons display rapid recovery from fast inactivation in a mouse model of amyotrophic lateral sclerosis. J. Neurophysiol. 96 (2006) 3314-3322